摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,11,17,23-tetraacetyl-25,26,27,28-tetrahydroxycalix[4]arene | 109894-43-1

中文名称
——
中文别名
——
英文名称
5,11,17,23-tetraacetyl-25,26,27,28-tetrahydroxycalix[4]arene
英文别名
1-(11,17,23-Triacetyl-25,26,27,28-tetrahydroxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl)ethanone
5,11,17,23-tetraacetyl-25,26,27,28-tetrahydroxycalix[4]arene化学式
CAS
109894-43-1
化学式
C36H32O8
mdl
——
分子量
592.645
InChiKey
TWVMVXIWKBCJOM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    44
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    149
  • 氢给体数:
    4
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,11,17,23-tetraacetyl-25,26,27,28-tetrahydroxycalix[4]arene 在 sodium azide 、 硫酸 作用下, 以 溶剂黄146 为溶剂, 以75%的产率得到5,11,17,23-tetraacetamido-25,26,27,28-tetrahydroxycalix<4>arene
    参考文献:
    名称:
    Morita, Yutaka; Agawa, Toshio; Kai, Yasushi, Chemistry Letters, 1989, p. 1349 - 1352
    摘要:
    DOI:
  • 作为产物:
    描述:
    25,26,27,28-O-tetraacetylcalix[4]arene 在 三氯化铝 作用下, 以 硝基苯 为溶剂, 以93%的产率得到5,11,17,23-tetraacetyl-25,26,27,28-tetrahydroxycalix[4]arene
    参考文献:
    名称:
    Syntheses and NMR behavior of calix[4]quinone and calix[4]hydroquinone
    摘要:
    Calix[4]quinone (7) and calix[4]hydroquinone (6) have been synthesis using three different synthetic pathways. The first pathway to 7 from calix[4]arene (1) consists of six steps: acetylation, Fries rearrangement, Baeyer-Villiger oxidation after acetylation, hydrolysis, and oxidation. The second pathway to 7 from 1 consists of four steps: acetylation, Fries rearrangement, reaction of the product obtained by Fries rearrangement with sodium azide, and oxidation. The third pathway to 7 from 1 is most convenient and consists of three steps: diazo coupling reaction, reduction, and oxidation. The NMR behavior of 6 and 7 is described.
    DOI:
    10.1021/jo00039a027
点击查看最新优质反应信息

文献信息

  • Regioselective Friedel–Crafts acylation of calix[4]arenes
    作者:Jan Skácel、Jan Budka、Václav Eigner、Pavel Lhoták
    DOI:10.1016/j.tet.2015.02.021
    日期:2015.4
    Friedel–Crafts acylation of 25,27-dialkoxycalix[4]arenes has been studied. Direct acylation of de-tert-butylated calixarene using acyl chlorides and AlCl3 in 1,2-dichloroethane provided the corresponding diacyl derivatives regioselectively in high yields. Furthermore, ipso-substitution in the tert-butylated series under the same reaction conditions is possible, albeit in lower yields. As indicated
    研究了25,27-二烷氧基杯[4]芳烃的Friedel-Crafts酰化反应。在1,2-二氯乙烷中使用酰氯和AlCl 3对叔丁基化的杯芳烃进行直接酰化,可选择性地高产率提供相应的二酰基衍生物。此外,本位在3'-取代叔-butylated相同的反应条件下系列是可能的,尽管较低的产率。如该化学不成功应用到指示ø -酰基衍生物,所述本位杯的酰化反应[4]芳烃前进通过在上边缘直接攻击,而不是由一个Fries重排机制。
  • Energy-Transfer Luminescence of Lanthanide Ions Encapsulated in Calix[4]arenes. Correlation between the Energy Level of Sensitizers and the Quantum Yield
    作者:Hitoshi Matsumoto、Seiji Shinkai
    DOI:10.1246/cl.1994.901
    日期:1994.5
    It was shown that the Tb3+ and Eu3+ complexes of 5,11,17,23-tetraacetyl-25,26,27,28-tetrakis(N,N-diethylaminocarbonylmethoxy)calix[4]arene give the high luminescence quantum yields (Φ = 0.164 for Tb3+ and 0.017 for Eu3+). The mechanistic investigations established that the high quantum yields are due to the energy level suitable to the energy-transfer and the presence of the carbonyl groups which mediate the intersystem crossing.
    研究表明,5,11,17,23-四乙酰基-25,26,27,28-四(N,N-二乙基氨基羰基甲氧基)钙[4]炔的 Tb3+ 和 Eu3+ 复合物具有很高的发光量子产率(Tb3+ 为 Φ = 0.164,Eu3+ 为 0.017)。机理研究表明,高量子产率得益于适合能量转移的能级以及介导系统间交叉的羰基的存在。
  • Calixbenoquin: Calixarene-Based Cluster of Monobenzone as a New Anti-Tyrosinase Agent
    作者:Fazel Nasuhi Pur
    DOI:10.1007/s11094-022-02777-x
    日期:2022.12
    Tyrosinase, copper-containing glycoprotein, is a key enzyme in the biosynthesis of melanin pigment from L-tyrosine. The excessive production of melanin in the skin due to skin disorders, such as melasma, is of great importance. Therefore, tyrosinase inhibitors are used for treatments of them. One of these inhibitors is monobenzone (benoquin) as a skin whitening agent, which has a phenolic structure. The phenolic structure of this drug, prompted the author to design its novel calix[4]arene-based cluster in a chalice-shaped structure. Therefore, the present study reports the synthesis and in vitro anti-tyrosinase of the chalice-shaped cluster of benoquin (namely calixbenoquin) in comparison to its simple drug unit (benoquin) as the reference medication. The synthetic route included chemical modification of the calix[4]arene structure by grafting four hydroxyl and benzyloxy groups on the upper and the lower rim of the calix[4]arene scaffold, respectively. The in vitro biological results showed an enhanced (about 4.5-fold) anti-tyrosinase activity for the calixarene-based cluster (calixbenoquin) in relation to its phenolic monomer (benoquin). Therefore, compared to benoquin, calixbenoquin with improved bioactivity can be considered as a new melanogenesis inhibitor with low dose range. These improved pharmaceutical effects are probably attributed to the clustering effect and improved interaction of four impacted benoquin units of the cluster with the active site of tyrosinase.
    酪氨酸酶是一种含铜的糖蛋白,是从L-酪氨酸合成黑色素的关键酶。由于皮肤疾病(如黄褐斑)引起的皮肤中黑色素的过度产生非常重要。因此,酪氨酸酶抑制剂被用于治疗这些疾病。其中一种抑制剂是苯甲酮(苯甲醌),它是一种具有酚类结构的皮肤美白剂。这种药物的酚类结构促使作者设计了一种具有杯状结构的新型杯[4]芳烃基簇。因此,本研究报道了苯甲酮(即杯苯甲醌)的杯状簇的合成和体外抗酪氨酸酶活性,并将其与作为参考药物的简单药物单元(苯甲醌)进行了比较。合成路线包括对杯[4]芳烃结构进行化学修饰,分别在杯[4]芳烃支架的上缘和下缘上嫁接四个羟基和苄氧基。体外生物学结果表明,与酚类单体(苯甲醌)相比,基于杯芳烃的簇(杯苯甲醌)的抗酪氨酸酶活性增强(约4.5倍)。因此,与苯甲醌相比,具有更高生物活性的杯苯甲醌可被视为一种低剂量的新型黑色素生成抑制剂。这些药物效果的改善可能归因于簇效应以及簇中四个受影响的苯甲醌单元
  • Huang, Zhi-Tang; Wang, Guo-Qiang, Chemische Berichte, 1994, vol. 127, # 3, p. 519 - 524
    作者:Huang, Zhi-Tang、Wang, Guo-Qiang
    DOI:——
    日期:——
  • Morita, Yutaka; Agawa, Toshio; Kai, Yasushi, Chemistry Letters, 1989, p. 1349 - 1352
    作者:Morita, Yutaka、Agawa, Toshio、Kai, Yasushi、Kanehisa, Nobuko、Kasai, Nobutami、et al.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐